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The ability of macrophages (Mos)  to function within an acidic environment has been shown 
to depend on cytoplasmic pH (pHi) regulation by vacuolar-type H + ATPases. Mcs metabolize 
t-arginine via an oxidative pathway that generates  nitric oxide,  nitrate, and nitrite. Since each 
of these products could potentially inhibit vacuolar-type H + ATPases, we investigated the effect 
of t-arginine metabolism on Me pHi regulation in thioglycolate-elicited  murine peritoneal Mcs. 
H +  ATPase-mediated  pHi  recovery  from an  imposed cytoplasmic acid  load was  measured 
fluorometrically. When Mcs were incubated with t-arginine (0.25-2.0 mM), their rate of pHi 
recovery declined progressively from 2 to 6 h of incubation. By contrast, the recovery rate of 
cells incubated in arginine-free  medium remained stable over the same period. The impairment 
of pHi recovery was specific for I.-arginine, and was blocked competitively by NG-monomethyl  - 
r-arginine, demonstrating its dependence on t-arginine metabolism. In addition, the inhibition 
of pHi recovery was enhanced by lipopolysaccharide,  an agent known to stimulate t-arginine 
metabolism by Mos.  Scavenging  the t-arginine metabolite nitric oxide with either ferrous 
sulphate or ferrous myoglobin prevented the inhibition of phi recovery, implying that t-arginine- 
derived nitric oxide was the species responsible for the inhibition. This concept was supported 
by the finding of elevated  nitrite levels in the supernatant ofceUs incubated in I.-arginine. Furthermore, 
incubation of Mcs with sodium nitroprusside mimicked the t-arginine-dependent inhibition of 
H + ATPase activity.  Treatment with the cyclic GMP analogue, 8-bromoguanosine 3':5'-cyclic 
monophosphate, similarly impaired Me phi recovery, suggesting that a nitric oxide-stimulated 
elevation of cyclic GMP may contribute to the r-arginine-dependent inhibition of pHi regulation. 
M 
aintenance of cytoplasmic pH (pHi) 1 within a narrow 
physiological range is crucial to the optimal function 
of mammalian cells. In macrophages (Mcs), the cytoplasmic 
compartment is particularly at risk for acid loading, due to 
both increased metabolic acid generation during cell activa- 
tion, and exposure to low extracellular pH (pHo) within the 
microenvironment of abscesses, tumors, or wounds (1-4). To 
offset  these challenges  to their internal milieu, Mos have 
evolved several mechanisms of pHi regulation. The best de- 
scribed  of these are: (a) the Na+/H + antiport, which ex- 
changes extracellular Na + for intracellular H + (5-8); and (b) 
the  Na+-dependent  HCO3-/C1-  exchanger,  which  ex- 
t Abbreviations used in this paper: BCECF, 2',7'-biscarboxyethyl-5(6)-carbo- 
xyttuorescein; IBMX, 3-isobutyl-l-methyl-xanthine;  Me, macrophage; 
N-MMA, NC-monomethyl-t-arginine;  pHi, cytophsmic  pH; pHo, extra- 
cellular pH. 
changes extracellular Na + and HCO3- for intracellular  CI- 
and possibly H + (9,  10). Both of these mechanisms serve 
to prevent cytoplasmic acidification when pHo is in the phys- 
iological range; however, both Na +/H + exchange and Na +- 
dependent HCO3-/C1-  exchange become compromised in 
an acidic milieu, due to low pHo and extracellular  HCO3- 
depletion, respectively  (11, 12). 
We have previously demonstrated that Mcs can recover 
from cytoplasmic acid loading by an additional, efficient mech- 
anism that maintains pHi in the physiological range even 
under acidic extracellular conditions (13): this mechanism ex- 
trudes protons from the cytoplasmic space into the extracel- 
lular medium in an ATP-dependent fashion (7, 14). The in- 
hibitor sensitivity profile, ionic dependence, and electrogenic 
properties of this mechanism are consistent with the concept 
that proton extrusion is mediated by plasmalemmal vacuolar- 
type H + ATPases (15, 16). This Na +- and HCO3--indepen- 
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Volume 174  November  1991  1009-1021 dent mechanism is inhibited by exposure of Mcs to nitrate 
or  to  sulfhydryl reagents  such  as  N-ethylmaleimide and 
7-chloro-4-nitrobenz-2-oxa-l,3-diazole  (16).  In  addition, 
proton extrusion by this mechanism is exquisitely sensitive 
to the macrolide antibiotic bafilomycin A1, which has been 
shown to be a potent and specific inhibitor of vacuolar-type 
H + ATPases (17). 
Several recent studies have defined the ability of Mcs to 
metabolize t-arginine via an oxidative pathway that yields 
L-citrulline as an end product (18, 19). A by-product of this 
metabolic pathway is the highly reactive species nitric oxide, 
which undergoes decomposition in the presence  of 02 and 
H20 to produce nitrite and nitrate (20-22). Nitric oxide is 
thought to be an effector molecule of several important Me 
functions, including tumor cytotoxicity  and antimicrobial ac- 
tivity (23-29).  These toxic effects  appear  to be mediated 
through inhibition of a variety of iron sulfur-dependent en- 
zymes by nitric oxide. In tumor cells, this leads to an impair- 
ment of mitochondrial respiration, with resultant depletion 
of intraceUular energy stores. The stable end product nitrite 
also exerts antimicrobial activity, through inhibition of en- 
zymes containing essential  sulfhydryl groups (30,  31). 
Mcs themselves have been found to be susceptible  to the 
toxic effects of t-arginine metabolism. Incubation with t-ar- 
ginine at concentrations typically  present in commercial media 
(0.4-1.14  mM) results in inhibition of M0 phagocytosis, su- 
peroxide production, and cytotoxicity (32). In addition, in- 
hibition of mitochondrial respiration occurs in M0s incubated 
with L-arginine  (33).  This could potentially lead to deple- 
tion of energy stores  in the M0s themselves,  as it does in 
target tumor cells. Because vacuolar-type H + ATPases can 
be inhibited by ATP depletion, by exposure to nitrate, or by 
a variety of sulfhydryl  reagents, it is conceivable that, through 
one or more of these mechanisms, t-arginine metabolism might 
modulate pHi regulation by vacuolar-type  H +  ATPases in 
Mcs. To test this possibility, we investigated the effect of z-ar- 
ginine on H + ATPase-mediated  pHi regulation in thiogly- 
colate-elicited peritoneal Mcs. 
Materials  and Methods 
Materials and Solutions.  Calcium- and magnesium-free  HBSS and 
RPMI 1640 select-amine kit medium were obtained from Gibco 
Laboratories (Grand Island, NY).  Heparin sodium) (1,000 USP 
U/ml) was from Organon Canada. Powdered brewer's thioglyco- 
late medium and LPS B (Escherichia coli O.111:B4) were obtained 
from Difco Laboratories (Detroit, MI), and ferrous sulphate was 
from Fisher Scientific  Co. (Pittsburgh, PA). Hepes, L-arginine,  D- 
arginine, t-homoarginine, t-citrulline, L-ornithine,  t-arginase (from 
bovine liver), t-ascorbic acid, myoglobin (from  horse skeletal 
muscle),  sodium  nitroprusside,  sodium  nitrite,  sulfanilamide, 
naphthylethylene diamine dihydrochloride, 3-isobutyl-l-methyl- 
xanthine (IBMX), and 8-bromoguanosine 3':5'-cyclic monophos- 
phate (sodium salt) were from Sigma  Chemical  Co. (St. Louis, MO). 
Nigericin,  NC-monomethyl-t-arginine  (N-MMA),  and  lu- 
ciferin/luciferase  ATP assay  kits were purchased from Calbiochem 
Behring Corp. (La Jolla, CA). The cGMP assay kits were from 
Amersham Corp. (Arlington Heights, IL).  The acetoxymethyl  ester 
of 2',7'-biscarboxyethyl-5(6)-carboxyfluorescein  (BCECF) was ob- 
tained from Molecular Probes (Eugene, OR.). Bafilomycin  A1 was 
the kind gift of Prof. K. Altendorf (Universt~it Osnabr~ick; see ref- 
erence 17). 
RPMI  select-amine kit medium was normally reconstituted 
without adding bicarbonate, although 25 mM sodium bicarbonate 
was included in medium used to enrich Mos by adherence, t-ar- 
ginine was omitted or added at the concentration indicated. All 
other components provided were included in the reconstituted 
medium.  Hepes-ILPMI was prepared by titrating  HCO3--free 
RPMI with 20 mM Na-Hepes to pH 7.35 at 37~  KC1 medium 
contained 145 mM KC1, 10 mM glucose, 2 mM CaC12, and 10 
mM Hepes, pH 7.35, at 37~  The osmolarity of KC1 medium 
was adjusted to 290 + 5 mosM with concentrated  KC1. Thioglyco- 
late medium was solubilized in H20 and stored in the dark at 
22~  until uniformly green. 
Celllsolation and Characterizalion.  Peritoneal  cells  were harvested 
from  6-8-wk-old  female Swiss Webster mice (Charles River 
Breeding Laboratories, Inc., Wilmington, MA) by lavage  with 10 
ml HBSS containing 10 U/ml heparin sodium, then washed twice 
with cold HBSS (5~  and counted using a cell counter (model 
ZF; Coulter Immunology, Hialeah, FL). Resident Mos were ob- 
tained from untreated mice, while thioglycolate-elicited  Mos were 
obtained by lavage 4 d after intraperitoneal injection with 2 ml 
of thioglycolate medium.  The  proportion  of peritoneal  cells 
identified as Mos by Wright's staining was consistently 80-85% 
for thioglycolate-elicited  cells, and 20-25% for resident cells. After 
washing, thioglyeolate-elicited cells were resuspended in Hepes- 
RPMI at 107 cells/ml for cell suspension experiments. 
For some experiments, Mos populations were enriched by ad- 
herence. Peritoneal cells in arginine-free Hepes-RPMI including 
25 mM sodium bicarbonate  were loaded  onto glass  coverslips  (Bellco 
Glass, Inc., Vineland, NJ) to achieve  a final number of ,v2  x  106/ 
coverslip. The coverslips were incubated for 2 h at 37~  in 5% 
CO2, then washed twice with warm HBSS (37~  Mo enrich- 
ment to >93% was confirmed by Wright's stain for both resident 
and thioglycolate-elicited  cells. The viability of  both adherent cells 
and cells in suspension was >95% as assessed by trypan blue ex- 
clusion. 
Incubation Conditions.  For cell suspension  experiments, 1-ml  ali- 
quots of thioglycolate-elicited  peritoneal cells (107 cells/ml Hepes- 
KPMI with or without L-arginine, as indicated) were incubated 
in a water bath at 37~  in room air. Cells were gently agitated 
every 15 min throughout the incubation period. After the indi- 
cated incubation period (2-6 h), a sample of the cell suspension 
was obtained for cytoplasmic  acid loading and subsequent measure- 
ment of pHi or acid extrusion, or for measurement of intraceUular 
ATP or cGMP. For some experiments, resident or thioglycolate- 
elicited Mos that had been enriched by adherence were incubated 
for a further 4 h in the presence of 10 #g/ml LPS at 37~  in room 
air in bicarbonate-free Hepes-KPMI, which was either arginine- 
free or contained 1.14 mM L-arginine. pHi was then measured at 
the 4-h time point,  as described below. 
phi Measurement and Manipulation.  pHi was measured using 
the pH-sensitive fluorescent probe, BCECF. For cell suspension 
experiments, 2  x  106 thioglycolate-elicited  cells were loaded with 
dye at the indicated time point by a 20-rain incubation in the same 
medium with 2/~g/ml of the precursor acetoxymethyl  ester at 37~ 
Cytoplasmic acid loading was accomplished  by simultaneous incu- 
bation with 40 mM NH4C1 during this 20-min period, followed 
by  sedimentation  and  resuspension in  2  ml  NH4+-free KC1 
medium in a fluorometer cuvette. The principles of the NH4 + 
"prepulse" technique of cytoplasmic  acid leading are described  rise- 
where (8, 11). The regimen used in these studies  consistently  yielded 
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loaded with dye by a 20-rain incubation in the same medium to 
which 2/*g/ml of the precursor acetoxymethyl ester was added. 
Cytoplasmic acid loading was achieved by simultaneous incuba- 
tion with 40 mM NH4C1 during the whole or latter part of this 
20-min period, followed by placement of the coversLip in 2 ml of 
NH4+-free KC1 medium in a fluorometer cuvette, so that the sur- 
face of the coverslip was oriented at 45 ~ to the incident excitation 
beam  (8).  A  20-min  incubation  with  NH4C1  resulted  in  acid 
loading to a pHi of -6.10 in adherent resident Mos, whether they 
had been incubated with  or without  t-arginine.  In the case of 
thioglycolate-elicited adherent Mos, it was necessary to adjust the 
length of the incubation with NH4C1  to obtain equivalent acid 
loading in cells that had been incubated with and without t-arginine. 
Specifically, to achieve acid loading to a pHi of "~6.80,  Mos that 
had been incubated in  arginine-free medium were treated  with 
NH4C1 for 20 rain, whereas Mos that had been incubated in t-ar- 
ginine-containing medium required only 9.5 min of exposure to 
NH4C1.  Fluorescence was determined using a fluorescence spec- 
trometer (650-40, LS-5, or LS-50; Perkin-Elmer Corp., Norwalk, 
CT) with excitation at 495  nm and emission at  525  nm using 
5- and 10-nm slits, respectively.  Calibration was done after addi- 
tion of the K+/H + ionophore nigericin (1 #M),  using aLiquots 
of concentrated 2-[morpholino] ethanesulfonic acid or Trizma base, 
as described (12), Recording of fluorescence commenced immedi- 
ately upon transfer of cells to KC1 medium,  and the initial rate 
of pHi recovery was measured. 
Measurement of Acid Extrusion.  Add efflux was detected by mea- 
suring pHo with  a conventional combination pH electrode in a 
water-jacket chamber containing 2 ml of KC1 medium prepared 
as above but without Hepes, to minimize the buffering power. After 
incubation in Hepes-RPMI with or without t-arginine, 2  x  106 
cells were sedimented, resuspended in '~20/.1 of the same medium, 
and added to the unbuffered KC1 medium, under continuous mag- 
netic stirring,  pHo was adjusted to 7.35  at 37~  by addition of 
KOH, and the change of pHo was then monitored.  Calibration 
was done by addition of known amounts of KOH and HC1, as 
described (14). 
Nitrite Analysis.  Thioglycolate-eLicited Mos were incubated for 
4 h at 37~  in Hepes-RPMI (107 cells/ml) in the absence or pres- 
ence of 1.14 mM t-arginine. Cells were pelleted and the nitrite con- 
tent of the supernatants determined in duplicate by reacting samples 
(100 pl) with the Griess reagent (50/*1 of 0.1% naphthylethylene 
diamiue dihydrochloride in H20 plus 50/*1  1% sulfanilamide in 
5% H3PO4) for 10 rain in a microplate well (note reference 34). 
Absorbance at 540 um was then measured, and nitrite concentra- 
tions were determined from a linear standard curve between 0 and 
64/*M  sodium nitrite. 
Measurement oflntracellular ATP.  Extraction was performed by 
addition  of 0.8  ml  ice  cold  perchloric  acid  (8%)  to  5  x  l& 
pelleted cells. This extract was neutralized with 0.45 ml of ice-cold 
K2CO3  (1 M), and clarified by centrifugation.  The ATP content 
of the cellular extracts was determined  using an ATP assay kit 
(Calbiochem-Behring  Corp.).  The  assay is  based  on  the  firefly 
luciferase-catalyzed  oxidation of I>luciferin in the presence of ATP, 
the concentration of which is quantitated by the amount of light 
produced.  The results were expressed as nanomoles of ATP per 
107 cells. 
Measurement of lntracellular cGMP.  Thioglycolate-elicited Mos 
were incubated for 4 h at 37~  in Hepes-RPMI (107 cells/ml) in 
the absence or presence of 1,14 mM t-arginine. For the final 20 
rain of the incubation period, IBMX (100/*M) was added. Extrac- 
tion was performed by addition of ice-cold ethanol to cell suspen- 
sions to give a final suspension volume of 65% ethanol. Superna- 
tants were clarified by centrifugation at 4~  and evaporated in a 
vacuum oven. The cGMP content of the samples was then deter- 
mined in duplicate, by RIA (Amersham Corp.). 
Statistics.  Results are presented as means  +  1 SE of n experi- 
ments. Statistical significance was established by one-way ANOVA 
followed by Newman-Keuls mukiple intergroup comparisons or 
by t test where indicated. 
Results 
Inhibitory Effect of z-Arginine  on H + ATPase-mediated phi 
Recovery.  To  examine  phi  regulation  by  H +  ATPases, 
recovery from cytoplasmic acid loading was studied in Na +- 
and HCO3--free KC1 medium, where neither Na+/H + ex- 
change nor HCO3-/C1-  exchange could restore pHi. Under 
these  conditions,  the  phi  of thioglycolate-elicited  Mes  in 
suspension nevertheless recovers rapidly, as illustrated in Fig. 
1 A. Between 85 and 90% of this pHi recovery is mediated 
A 
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Figure 1. 
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Effect of t-arginine  on H § ATPase-mediated pHi recovery 
of acid-loaded macrophages, pHi was measured fluorometrically using the 
probe BCECF. Freshly harvested thioglycolate-dicited  peritoneal cells were 
incubated for 4 h at 37~  in t-arginine-containing (lower  trace in A, upper 
trace in B) or arginine-free (upper trace in A, lower  trace in B) bicarbonate- 
free Hepes-RPMI (107 cells/ml). Cells were then acid loaded by the NH4 + 
prepulse method by preincubating 2  x  106 cells for 20 rain at 37~  in 
the same medium, to which NH4CI was added (40 raM, final concentra- 
tion); this was done in the absence (A) or presence (B) of bafilomycin 
At (100 nlVi). Traces begin immediately upon resuspension of cells in 2 
ml of NH4+-free KC1 medium in a fluorometer cuwtte.  In each trace, 
nigericin (1 #M) was added where indicated by the arrows, for purposes 
of calibration. Traces are representative of four experiments. Temperature 
was 37~ 
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to nanomolar concentrations of bafilomycin A1, the potent, 
specific inhibitor of vacuolar-type H + ATPases (compare Fig. 
1 B A;  see references 15 and 17). 
The NH4 + prepulse technique achieved a comparable de- 
gree of acid loading in Mcs incubated with and without t-ar- 
ginine (Fig. 1 A). Incubation for 4 h in t-arginine-containing 
medium  reduced  the  initial  rate  of Na +-  and  HCO3-- 
independent  phi  recovery  compared  to  incubation  in 
arginine~free medium (0.67  _+ 0.04 and 0.84 +_ 0.02 pH/min, 
respectively; n  =  4; p < 0.05; Fig. 1 A). This suggested that 
incubation with t-arginine was capable of inhibiting  H + 
ATPase-mediated phi recovery. The inhibitory effect of t-ar- 
ginine on pHi recovery of thioglycolate-elicited cells was also 
observed in adherence-enriched Me cell populations, where 
phi recovery rates were 0.20  _+  0.02 vs. 0.13  +  0.02 pH/ 
min in cells incubated in arginine-free vs. arginine-containing 
media, respectively (p <  0.05;  n  =  6).  It should be noted 
that in adherent cells, the initial pHi recovery rate appears 
slower than in suspended cells. This apparent discrepancy is 
due to the fact that the adherent cells were acidified to pH 
6.80  vs.  pH  6.40  for  suspended cells  (see  Materials  and 
Methods). Previous studies have shown that the initial rate 
of phi recovery mediated by H + ATPases is directly propor- 
tional  to  the magnitude of the imposed acid load (C. J. 
Swallow et al., unpublished observations). 
In  both  suspended  and  plated  Mcs,  a  small  portion 
(10-15%)  of  total  Na +-  and  HCO3--independent  phi 
recovery was not mediated by vacuolar-type H + ATPases, as 
determined by its insensitivity to bafilomycin A1 (15). It was 
therefore conceivable that incubation with I.-arginine inhibited 
total pHi recovery by reducing the bafilomycin-insensitive 
component of this recovery. To rule out this possibility, the 
effect of t-arginine on Na +- and HCO3--independent pHi 
recovery  was  studied  in  suspended  cells  treated  with 
bafilomycin A1.  As shown in Fig.  1 B, t-arginine had no 
effect on the bafilomycin-insensitive component of the phi 
recovery (the recovery rates in bafilomycin-treated cells were 
0.09  +  0.02  and 0.10  +  0.02  pH/min  after incubation 
without and with t-arginine, respectively; n  =  4); this re- 
sult is consistent with the conclusion that t-arginine impairs 
H §  ATPase-mediated pHi regulation. 
The time course of the inhibition of pHi recovery by t-ar- 
ginine is shown in Table 1. The initial rate of pHi recovery 
from acid loading declined progressively from 2 to 6 h  in 
Mcs incubated in the presence of 1.14 mM t-arginine. By 
contrast, when Mcs were incubated in arginine-free medium, 
the rate of pHi recovery from acid loading remained stable. 
Me viability was >90% over the 6-h incubation period, both 
with and without r.-arginine, with no difference between the 
two incubation conditions. Thus, the presence of t-arginine 
in the incubation medium appeared to be associated  with a 
progressive inhibition of H + ATPase-mediated phi recovery. 
Two alternative explanations for this apparent inhibition 
of H +  pump  activity were considered.  First,  incubation 
with r.-arginine might increase Me buffering capacity. If this 
were the case, for the same amount of acid extruded by H + 
Table  1.  Effect of t-Arginine on Macrophage Cytoplasmic 
pH Recovery 
Initial rate of cytoplasmic pH recovery" 
Medium  LPS  2 h  4 h  6 h 
pH/min 
+  L-Arginine  -  0.78+_0.07  0.67 +_ 0.04~  0.51+_0.03 *s 
Arginine-free  -  0.82 + 0.04  0.84 + 0.0211  0.84 + 0.0211 
+  t-Arginine  +  0.45 _+ 0.04 II  0.46 _+ 0.03 II  0.47 +_ 0.05 
Arginine-free  +  0.76 + 0.021  0.72 + 0.021  0.77 + 0.031 
* Freshly harvested thioglycolate-elicited  peritoneal  cells were incubated 
at 37~  for the indicated  time period in bicarbonate-free  Hepes-RPMl 
(107 cells/ml) with or without 1,14 mM L-arginine, in the presence or 
absence of LPS (10/lg/ml). Cells were then acid loaded by the NH4 + 
prepulse method by incubating  2  x  106 cells for 20 min at 37~  in the 
same medium, to which NH4CI (40 mM final concentration)  was  ad- 
ded.  The initial  rate of cytoplasmic  pH recovery  after  resuspension  in 
NH4+-free KC1 medium was  then measured  fluorometrically.  Results 
are expressed as means  +_  1 SE of three to four experiments. 
p<0.05vs,  t  =  2h. 
p<0.05vs,  t  =  4h. 
IIp <  0.05  vs.  +  r-arginine without LPS. 
I p  <  0.02  vs.  +  t-arginine with LPS. 
ATPases,  the rate of pHi recovery would appear reduced. 
This  possibility  seemed  unlikely,  since  the  same  NH4 + 
prepulse conditions resulted in comparable acid loading in 
suspended cells incubated with and without t-arginine. Second, 
incubation with t-arginine might conceivably increase the 
rate of continuous metabolic acid generation sufficiently to 
slow the rate of pHi recovery from a  superimposed acute 
Table  2.  Effect of r-Arginine  on the Rate of Acid Extrusion  by 
Acid-loaded Macrophages 
Rate of Acid Extrusion* 
Medium  2  h  4  h  6  h 
nmol/min/I& cells 
+  r-Arginine  9.27  +  1.41  6.42  +_  1.04  5,33  +_  0,33 t 
Arginine-free  9.18  +_  0.87  8.14  _+  0.75  8.46  _+  0.77 
* Freshly harvested thioglycolate-elicited  peritoneal  cells were incubated 
at 370C for the indicated  time period in bicarbonate-free  Hepes-ILPMI 
(107 ceUs/ml) with or without 1.14 mM t-arginine.  Cells were then acid 
loaded by the NH4*  prepulse method by incubating 2  x  106 cells for 
20 min at 37~  in the same medium, to which NH4C1 (40 mM final 
concentration) was added. The initial rate of acid extrusion after resuspen- 
sion in NH4 +-flee KCI medium was then measured using a conventional 
pH electrode,  Results  are means  _+  1 SE of four experiments. 
p  <  0.05  vs.  t  =  2 h,  and vs.  arginine-free. 
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Figure 2.  Effect  of r-arginine, D-arginine, t-homoarginine, t-ornithine, urea, t-arginase, or N-MMA on pHi recovery  of acid-loaded macrophages. 
Thioglycolate-elicited peritoneal cells were incubated for 4 h at 37~  in bicarbonate-free Hepes-R.PMI (10  ~ cells/ml) in the presence or absence of 
t-arginine, with or without  the indicated compounds. After this incubation, 2  x  10~ cells were incubated for a further 20 rain in the same medium, 
in the presence of 40 mM NH4C1. Cells were then resuspended in NH4*-free KC1 medium, resulting in acid loading to phi r~6.4, as illustrated in 
Fig. 1. After calibration, the initial rate of pHi recovery was calculated. (.4) Cells were incubated for 4 h with various concentrations of t-arginine. 
The inhibition of phi recovery associated with each concentration of t-arginine is expressed as a percentage of the maximal inhibition observed on 
each given day. The mean maximal inhibition was 0.33 •  0.06 pH/min; n =  5. "p < 0.05 vs. no t-arginine. (B) Cells were incubated for 4 h with 
or without 1.14 mM t-arginine, in the absence or presence of t-arginase (10 U/ml) plus MnCI2.4H20 (10 #g/liter).  *p < 0.01 vs. no r-arginase, and 
vs. 1.14 mM t-arginine plus arginase; n =  3. (C) Cells were incubated for 4 h in medium containing no t-arginine or 1.14 mM of either t-arginine, 
D-arginine, t-homoarginine, t-ornithine, or urea. *p < 0.05 vs. no L-arginine, vs. D-arginine, vs. t-ornithine, and vs. urea; n =  5. (D) Cells were in- 
cubated for 4 h in medium containing no t-arginine or t-arginine at a concentration of 1.14 or 11.4 mM, with or without  0.1 mM N-MMA, as 
indicated. *p < 0.05 vs. no t-arginine and vs. 1.14 mM t-arginine plus 0.1 mM N-MMA; n  =  4. 
acid load.  To determine whether either of these possibilities 
were responsible for the apparent inhibition of H + ATPase 
activity, the rate of add extrusion into the extracellular  medium 
by acid-loaded Mes was measured directly. Table 2 shows the 
rate of acid extrusion into unbuffered KC1 medium by acid- 
loaded Mcs, which had been incubated in either t-arginine- 
containing or arginine-ffee medium.  Incubation with t-ar- 
ginine resulted in a progressive reduction in the rate of acid 
extrusion by acid-loaded Mcs over the experimental period, 
while this  rate remained relatively stable in cells incubated 
in arginine-ffee medium.  The parallel reduction in the rates 
of acid extrusion and pHi recovery implies that the effect of 
t-arginine is due to inhibition of H + pump activity, rather 
than  increased cytoplasmic buffering capacity or enhanced 
metabolic acid production. 
To better define the role of t-arginine in modulating Me 
phi recovery, the effect of incubation with varying doses of 
t-arginine  was examined  (Fig.  2 A).  The inhibitory effect 
of each  concentration  of t-arginine  on  the  initial  rate  of 
Na +- and HCO3--independent phi recovery is expressed as 
a percentage of the maximal inhibition observed on each given 
day (maximal inhibition was defined as the difference between 
the rates  of recovery in Mcs incubated without t-arginine 
and Mcs incubated with the most inhibitory concentration 
of r-arginine).  The rate of pHi recovery varied inversely with 
the concentration of t-arginine in the incubation medium. 
1013  Swallow  et al. pHi recovery was significantly impaired by incubation with 
concentrations of t-arginine as low as 0.25 mM (0.61 + 0.06 
pH/min vs. 0.83  _  0.09 pH/min in arginine-ffee medium; 
n =  5; p < 0.05). Incubation with 2 mM t-arginine did not 
result in any further reduction of the pHi recovery rate at 
4 h compared to incubation with 1.14 mM L-arginine (0.53 
_  0.05 vs. 0.55  +_  0.05 pH/min, respectively). 
Inhibition of pH~ Recovery Is  Specific for t-Arginine,  To 
confirm  that  the  inhibition  of  pHi  recovery  was  due 
specifically to the presence of t-arginine in the incubation 
medium, rather than to a contaminant, the effect of exoge- 
nous L-arginase on phi recovery was studied. This enzyme 
depletes t-arginine by converting it to L-ornithine plus urea. 
As  shown in Fig.  2 B,  10 U/m1 L-arginase plus MnC12. 
4H20 (an arginase activator, 10/~g/llter) reversed the inhibi- 
tory effect of L-arginine on pHi recovery (n =  3; p < 0.01). 
By contrast,  addition of 10 U/ml L-arginase to arginine-free 
medium had no effect on the pHi  recovery rate,  thereby 
ruling out a nonspecific stimulatory effect of arginase on pHi 
recovery. 
M0s themselves can release significant amounts of endog- 
enous g-arginase (35). This suggested the possibility that the 
inhibition of pHi recovery might be mediated by L-ornithine 
or urea derived from l.-arginine through the action of endog- 
enous t-arginase. The ability of exogenous t-arginase to re- 
verse the inhibition,  rather than accentuate it, made it un- 
likely that the generation of t-ornithine or urea was responsible 
for the inhibition.  To directly rule out this possibility, Mcs 
were incubated in arginine-free medium supplemented with 
1.14 mM of either t-ornithine or urea. As illustrated in Fig. 
2 C, neither compound had any effect on pHi recovery com- 
pared to arginine-free medium alone. When considered to- 
gether,  these data provide strong evidence that the inhibi- 
tory effect was specifically  rdated to the presence of t-arginine 
in the incubation medium. 
To investigate the substrate specificity of the inhibition of 
H § ATPase-mediated pHi recovery, the effect of incubation 
with the D-stereoisomer of arginine was compared to that 
of incubation with t-stereoisomer of arginine was compared 
to that of incubation with L-arginine itself (Fig. 2 C). The 
rate of phi recovery after a 4-h incubation with o-arginine 
did not differ from that observed in Mcs incubated in the 
absence of arginine (0.86  +_. 0.07 vs. 0.81  __. 0.08 pH/min, 
respectively; n =  5). By contrast, incubation with L-arginine 
reduced the pHi recovery rate to 0.57  _+  0.05 pH/min (n 
--  5; p < 0.05 vs. D-arginine). These results indicated that 
the inhibition of H + ATPase activity had a specific require- 
ment for the t-stereoisomer of arginine, likely through its 
oxidative metabolism. 
Inhibition of pHi  Recovery Requires Metabolism of t-Ar- 
ginine.  A variety of cell types, including Mcs, have been 
shown to metabolize t-arginine through a series of oxidative 
reactions that yield t-citrulline, nitrite, and nitrate as stable 
end products (18, 19, 22, 36). It was hypothesized that the 
t-arginine-dependent inhibition  of pHi  recovery required 
metabolism of L-arginine  via this pathway. This was suggested 
by the fact that the nonmetabolizable D-stereoisomer of argi- 
nine had no such inhibitory effect. However, it was still possible 
that the inhibition of H + ATPase-mediated pHi  recovery 
was due to the presence of extracellular r.-arginine,  rather than 
to its metabolism by Mcs. To further investigate the require- 
ment for metabolism, the effect of t-homoarginine (32, 36) 
on pHi recovery was examined. As illustrated in Fig. 2 C, 
this metabolizable analogue mimicked the inhibitory effect 
of t-arginine on pHi recovery. 
Further evidence  that metabolism of t-arginine was required 
for the inhibition of pHi recovery was obtained from experi- 
ments using N-MMA, a potent, specific, competitive inhib- 
itor of  t-arginine metabolism. The effect of coincubation with 
N-MMA in the presence of I.-arginine was studied (Fig. 2 
D). N-MMA prevented the inhibition of phi recovery in- 
duced by I.-arginine: the rate of pHi recovery after incuba- 
tion in the presence of 1.14 mM I.-arginine with 0.1 mM 
N-MMA was comparable to that seen in cells incubated in 
arginine-free  medium (0.74 + 0.07 and 0.79 + 0.06 pH/min, 
respectively; n  =  4), while the pHi recovery rate in Mcs in- 
cubated with 1.14 mM t-arginine alone was 0.56  _+  0.05 
pH/min (n  =  4; p  <  0.05  vs.  1.14 mM t-arginine plus 
N-MMA). The ability of N-MMA to prevent the t-arginine- 
dependent inhibition of pHi recovery was overcome by in- 
cubation with a higher concentration of t-arginine: the rate 
of pHi recovery of Mcs incubated  for 4 h in the presence 
of 0.1 mM N-MMA was 0.53  _+  0.04 pH/min when 11.4 
rather than 1.14 mM t-arginine was included in the incuba- 
tion  medium  (Fig.  2  D).  This  indicated  that  N-MMA 
prevented the inhibition  of pHi recovery by competing with 
t-arginine. The demonstration of competitive inhibition by 
N-MMA confirmed that the inhibitory effect of incubation 
with t-arginine on pHi recovery was mediated through me- 
tabolism of L-arginine. 
Enhancement  of  t-arginine-dependent Inhibition of phi 
Recovery by LPS.  Treatment of Mos with LPS is known to 
stimulate metabolism of L-arginine to t-citrulline, and thus 
to enhance release of the highly reactive metabolite,  nitric 
oxide, as well as of nitrite/nitrate (19, 22, 37). We therefore 
hypothesized that the t-arginine-dependent inhibition of H + 
ATPase-mediated pHi recovery might be enhanced by LPS. 
To test this possibility, the effect of LPS (10 #g/ml) on phi 
recovery was  examined  (Table 1).  Mr  viability  remained 
>88% over the course of 6 h of incubation with 10/xg/ml 
LPS, both in the presence and absence of r-arginine, and did 
not differ between groups, pHi recovery after incubation for 
2 h in the presence of 1.14 mM L-arginine was markedly re- 
duced in LPS-treated cells compared to control cells (0.45 
+  0.04 vs. 0.78  +  0.07 pH/min, respectively; n  =  3; p < 
0.001). By contrast, when Mcs were incubated  for 2 h in 
arginine-free  medium,  the rate  of pHi  recovery of LPS- 
treated cells approximated  that seen in control cells. This 
demonstrated the t-arginine dependence of the LPS-mediated 
inhibition of pHi recovery. The difference in pHi recovery 
rates between LPS-treated Mcs incubated with and without 
L-arginine persisted after 4 h (Table 1), demonstrating the 
ongoing t-arginine dependence of the LPS-induced inhibi- 
tion of pHi recovery. By 6 h, the mean pHi recovery rate in 
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Figure 3.  Effect  of LPS  on t-arginine-dependent  inhibition  of H + 
ATPase-mediated pHi recovery of acid-loaded macrophages. Thioglycolate- 
elicited peritoneal  cells were incubated  for 2 h at 37~  in Hepes-RPMI 
(107 cell/ml) with 1.14 mM t-arginine, without or with various concen- 
trations  of LPS. 2  x  106 cells were then incubated  for a further 20 min 
in the same medium, in the presence of 40 mM NH4C1. The initial rate 
of pHi recovery after resuspension in NH4 +-free KCI medium was then 
measured fluorometrically. The inhibition of pHi recovery associated with 
each incubation condition is expressed as a percentage of the maximal in- 
hibition observed on each given day. The mean maximal inhibition was 
0.31  +  0.04  pH/min; n  =  4.  *p <  0.05  vs. no LPS. 
Mcs incubated with t-arginine but without LPS approxi- 
mated that seen in cells incubated with both (0.51  +  0.03 
and 0.47  +_  0.05 pH/min, respectively;  n  =  4). 
The ability of various concentrations of LPS to promote 
r-arginine-dependent inhibition of pHi recovery was studied 
in Mcs incubated in the presence of 1.14 mM L-arginine for 
2 h (Fig. 3). Incubation with as little as 10 ng/ml LPS resulted 
in a significant inhibition of pHi recovery compared to con- 
trol cells incubated with t-arginine but without LPS (0.53 
_+ 0.06 vs. 0.75  _+ 0.06 pH/min, respectively; n  =  4;/~ < 
0.05). There was no further enhancement of the inhibition 
when the concentration of LPS was increased beyond 0.1 
/~g/ml. 
Nitric Oxide Mediates the z-Arginine-dependent Inhibition of 
pHi Recovery.  Since Me metabolism of I.-arginine leads to 
the generation of t-citrulline, nitrite, and nitrate as stable end 
products (18-20, 22),  the possibility that one of these me- 
tabolites was responsible for the inhibition of H + ATPase- 
mediated pHi regulation was examined. Neither nitrate nor 
t-citrulline (up to 10 raM) was able to inhibit pHi recovery 
(data  not shown). 
The short-lived intermediate nitric oxide reacts with and 
inhibits a variety of enzymes, including several in the citric 
acid cycle and the mitochondrial electron transport chain (18, 
25-27). We hypothesized that nitric oxide was the L-arginine 
metabolite responsible for the observed inhibition of H + 
ATPase-mediated  pHi  recovery.  Several approaches  were 
taken to test this hypothesis. First, the effect of scavenging 
nitric oxide on the T.-arginine-dependent inhibition of pHi 
recovery was examined. A combination of ferrous sulphate 
(100 #M) and ascorbate  (1 mM) was used to generate the 
nitric oxide scavenger, superoxide (23).  Superoxide anions 
avidly react with nitric oxide, markedly shortening its phar- 
macologic half-life (38,  39). 
As shown in Fig. 4 A, simultaneous incubation with this 
scavenging system reversed the inhibitory effect of t-arginine 
plus LPS  on pHi recovery.  Ascorbate alone had no such 
effect. In addition, ferrous sulphate plus ascorbate had no effect 
on the pHi recovery of cells incubated in arginine-free  me- 
dium, arguing against a  nonspecific stimulatory effect of 
ferrous sulphate and ascorbate on phi recovery. A second ni- 
tric oxide scavenging system, with a different mode of ac- 
tion, was also tested. When kept in the ferrous state, heine 
proteins such as hemoglobin and myoglobin avidly bind and 
inactivate nitric oxide (23,  40, 41). Fig.  4 B illustrates  the 
effect of coincubation with myoglobin and ascorbate on the 
pHi recovery of Mcs incubated with t-arginine and LPS (10 
/~g/ml). This scavenging system was similarly  effective in 
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Figure 4.  Effect of scavenging nitric oxide on the L-arginine-dependent 
inhibition of pHi recovery in acid-loaded  macrophages.  Thioglycdate- 
elicited peritoneal  cells were incubated.for  2 h at 37~  in Hepes-RPM! 
(107 cells/ml) with or without 1.14 mM t-arginine, in the presence of 10 
#g/ml LPS. 2  x  106 cells were incubated for a further 20 min in the same 
medium,  in  the presence  of 40  mM  NH4C1.  The initial  rate  of phi 
recovery after resuspension in NH4+-free KC1 medium was then measured 
fluorometrically.  (A) Cells were incubated without or with either ferrous 
sulphate (Fe sulphate,  100/~M) plus ascorbate (1 mM) or ascorbate alone 
(1 raM) throughout the entire 140-min incubation period.  *p < 0.05 vs. 
no t-arginine and vs. t-arginine and ferrous sulphate plus ascorbate; n  = 
4. (B) Cells were incubated without or with either myoglobin (3 mg/ml) 
plus ascorbate (1 mM) or ascorbate alone (1 raM) throughout the entire 
140-min incubation period.  *p < 0.05 vs. no t-arginine and vs. t-arginine 
and myoglobin plus ascorbate;  n  =  4. 
1015  Swallow et al. abrogating the inhibition of pHi recovery normally observed 
in cells incubated with t-arginine. Prevention of the t-arginine~ 
dependent inhibition of pHi recovery by two distinct nitric 
oxide scavenging  systems  suggested that the t-arginine metabo- 
lite responsible for the inhibition is nitric oxide. 
This concept was further supported by examining the effect 
of nitroprusside  on phi recovery. This vasodilator has been 
shown to spontaneously generate nitric oxide. If nitric oxide 
were the species responsible for inhibition of H + ATPase- 
mediated pHi recovery, nitroprusside  would be expected to 
mimic this inhibition by acting as an exogenous source of 
nitric oxide. To determine its effect on pHi recovery, sodium 
nitroprusside (1 mM) was added to Mcs after a 2-h preincu- 
bation in arginine-free medium. Incubation with nitroprus- 
side for 20 min significantly reduced the rate of pHi recovery 
from acid loading  (0.37  _+  0.08 vs. 0.70  _+  0.04 pH/min 
in nitroprusside-treated  vs. control cells, respectively; n  = 
4; p < 0.05). Representative analogue tracings that demon- 
strate  this  inhibition are shown in Fig. 5 A.  These data 
suggested that nitroprusside was able to inhibit H + ATPase- 
mediated pHi recovery. To confirm that the observed impair- 
ment  of pHi  recovery was  due to  inhibition  of the H § 
ATPase-mediated component of Na +-  and  HCO3--inde- 
pendent recovery, the effect of nitroprusside  on bafilomycin 
Al-insensitive pHi recovery was examined. As shown in Fig. 
5 B, incubation  for 20 min with 1 mM nitroprusside  had 
no effect on the pHi recovery rate of bafilomycin At-treated 
cells,  indicating  that  the  component  of  the  Na §  and 
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Figure 5.  Effect of nitroprusside  on H + ATPase-mediated pHi recovery of acid-loaded macrophages. Thioglycolate-elicited  peritoneal cells were in- 
cubated  for 2 h at 37~  in arginine-free Hepes-RPMI (107 cells/ml).  Cells were then acid loaded by the NH4 + prepulse method by incubating 2  x 
106 cells for a further 20 min at 37~  in the same medium, to which NH4CI was added (40 mM, final concentration);  this 20-min  incubation  was 
done in the presence (B) or absence (,'1 and C) of bafilomycin A1. phi recovery after resuspension  in NH4+-free  KC1 medium was then measured 
fluorometrically.  Where indicated  (lower trace in A, upper trace in B, filled circles in C) sodium  nitroprusside  (1 raM) was added for the final 20 rain, 
synchronous  with the incubation  with NH4C1 (A and B),  or for the time period indicated,  synchronous  with the incubation  with NH4CI  +  the 
final 10 min of the 2-h preincubation  (C).  Control cells were incubated  in parallel in arginine-free medium without nitroprusside  (upper trace in A, 
lower trace in B, open circles in C). Traces begin immediately upon resuspension of cells in 2 ml of NH4 +  -free KC1 medium in a fluorometer  cuvette. 
In each trace, nigericin (1/~M) was added where indicated by the arrows, for purposes of calibration. (A and B) Traces are presentative of four experiments. 
Temperature was 37~  (C) The inhibition of initial pHi recovery at each time point is expressed as a percentage of the maximal inhibition observed 
on each given day. The mean maximal  inhibition was 0.42  +-  0.05  pH/min; n  =  4.  *p <  0.05 vs. time  =  0 vs. without nitroprusside. 
1016  L-Arginine  and Macrophage  Cytoplasmic  pH HCO3--independent pHi recovery inhibited by nitroprus- 
side in Fig. 5 A was the H + ATPase-mediated recovery. Ni- 
tric oxide-induced relaxation of smooth muscle occurs within 
1 min of exposure to nitroprusside (42). The effect of nitro- 
prusside on Me pHi recovery was similarly rapid in onset: 
inhibition was apparent within the first few minutes of incu- 
bation with nitroprusside (Fig.  5  C). 
Finally, solution decomposition under standard experimental 
conditions yields nitrite and nitrate as stable end products. 
Accumulation of nitrite/nitrate thus reflects cellular nitric oxide 
production. Incubation of cells in arginine-containing medium 
for 4 h  resulted in a significant increase in nitrite levels in 
the supernatant compared to cells incubated in arginine-free 
medium (2.33  •  0.26 #M vs.  1.69  •  0.29 #M;  n  =  13; 
p <  0.05). When considered together with the studies pre- 
sented  above  using  nitric  oxide  scavengers  and  sodium 
nitroprusside, these data further support the concept that the 
t-arginine-dependent impairment of pHi regulation is medi- 
ated through the action of nitric oxide. 
Mechanism  of Nitric  Oxide-induced  Inhibition  of pHi Re- 
covery.  Nitric oxide has been shown to impair mitochon- 
drial respiration in both target cells and in Mcs themselves, 
by inhibiting the aconitase of the citric acid cycle and the 
NADH/ubiquinone and succinate/ubiquinone oxidoreduc- 
tase of the mitochondrial electron transport chain (26,  27, 
33, 36). Such inhibition of mitochondrial respiration could 
potentially lead to ATP depletion. Since bafalomycin-sensitive 
proton pumping is ATP dependent, nitric oxide-induced ATP 
depletion represented one possible mechanism by which t-ar- 
ginine metabolism could inhibit the regulation of Me pHi 
by H + ATPases. To investigate this possibility,  the ATP con- 
tent of cells incubated in the presence or absence of L-arginine, 
with or without LPS, was measured (Table 3). Over the 6-h 
incubation period, there was a gradual ATP depletion ob- 
Cellular ATP 
0bl  0'.1  1'.o  ld.o 
[8-bromo  cGMP] (raM) 
Medium  LPS  2 h  4 h  6 h 
nmol/lO 7 cells 
+  t-Arginine  -  17.4  _+ 2.3  16.7 _+ 3.0  11.3 _+ 2.9* 
Arginine-free  -  20.0  +  2.9  16.3 _+ 3.2  11.2 _+ 3.1' 
+  t-Arginine  +  17.6  _+ 3.1  16.6 _+ 3.2  11.2 _+ 2.8* 
Arginine-free  +  19.5  _+ 2.4  17.2 _+ 3.0  11.3 +_ 3.1~ 
* Freshly harvested thioglycolate-elicited peritoneal cells were incubated 
at 37~  for the indicated time period in bicarbonate-free Hepes-RPMI 
(107 cells/ml) with or without 1.14 mM t-arginine, in the presence or 
absence of LPS (10 #g/ml), as indicated. 5  x  106 cells were then pellet- 
ed, extracted with perchloric acid, and ATP content was determined us- 
ing the luciferin/luciferase assay system.  The ATP content of freshly 
harvested cells was 22.1  +_  2.6 nmol/10  ~ cells. Results are expressed  as 
means  _+  1 SE of four to six experiments. 
*p<0.05vs.  t  =  0. 
served in all groups. The reason for the gradual decline in 
cellular ATP content is not clear. It is unlikely to result from 
progressive adherence of the Mcs to the incubation tubes, 
since extraction was performed by adding perchloric acid 
directly to the tubes. A more likely alternative explanation 
was that, although viability remained high, the general con- 
dition of the cells slowly deteriorated over the course of the 
6-h incubation ex vivo.  However, there were no significant 
differences in ATP levels among the various groups at any 
time point.  These results indicate that inhibition of mito- 
chondrial respiration with resultant ATP depletion is not the 
mechanism  whereby  nitric  oxide  impairs  H +  ATPase- 
mediated pHi recovery. 
One further possibility is that t-arginine-derived nitric oxide 
might activate guanylate cyclase, resulting in an increase in 
the second messenger cyclic GMP (43-45). The vasorelaxant 
effect of nitric oxide is mediated through elevation of cGMP 
in vascular smooth muscle cells (18, 43, 44). To test the hy- 
pothesis that an elevation in cGMP might be responsible for 
the observed inhibition  of Me pHi regulation,  Mcs were 
treated with a membrane-permeant form of this second mes- 
senger,  8-bromoguanosine Y:5'-cyclic monophosphate  (8- 
bromo cGMP),  after a  2-h preincubation in  arginine-free 
medium. As shown in Fig. 6, exposure to 8-bromo cGMP 
(100 #M to 10 mM) significantly reduced the pHi recovery 
rate of acid-loaded Mcs (the rate of recovery was 0.52  _+ 0.04 
pH/min after incubation with 1 mM 8-bromo cGMP vs. 0.76 
+  0.06 pH/min in control cells; n  =  4; p <  0.05). In fur- 
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Table  3.  Effect of r-Arginine on Cellular ATP Content 
Figure 6.  Effect of 8-bromo cGMP on the H + ATPase-mediated  pHi 
recovery of acid-loaded macrophages. Freshly harvested thioglycohte-elidted 
peritoneal cells were incubated for 2 h at 37~  in arginine-free Hepes- 
RPMI (107 cells/ml). 2  x  106 cells were incubated for a further 20 min 
in the same medium, in the presence of 40 mM NH4C1. The initial rate 
of pHi recovery after resuspension in NHC-free KC1 medium was then 
measured fluorometrically.  The indicated concentration of 8-bromo cGMP 
was present during the final 10 min of the 2-h of preincubation and 
throughout the 20-min incubation with NH4CI. The inhibition of phi 
recovery associated with each concentration of t-arginine is expressed as 
a percentage of the maximal inhibition observed on each given day. The 
mean maximal inhibition was 0.30  _+ 0.01 pH/min; n  =  4. Where ab- 
sent, the error bar was smaller than the symbol. *p < 0.05 vs. no 8-bromo 
cGMP. 
1017  Swallow  et al. ther support of this concept, nitroprusside  (1 mM), shown 
above to inhibit pHi recovery caused a significant rise in in- 
tracellular cGMP within 30 min after addition to cells (0.187 
_+ 0.023 pmol/mg protein; n = 3 vs. 0.037 _+ 0.011 pmol/mg 
protein; n =  3;/~ < 0.001). However, total intracellular cGMP 
was not measurably different in cells incubated  for 4 h in 
t-arginine-containing vs. arginine--free  medium (0.084  +  0.018 
pmol/mg protein;  n  =  7 vs. 0.070  +_  0.019 pmol/mg pro- 
tein;  n  =  7,  respectively). 
Discussion 
Our previous studies defined the presence of H + extru- 
sion mediated by vacuolar-type H § ATPases in murine peri- 
toneal Mcs. These proton pumps constituted a prominent 
pHi regulatory mechanism, and were found to be critical to 
the preservation  of normal Me function within an acidic 
milieu (13). The present studies demonstrate that H + pump- 
mediated pHi regulation may be modulated by an t-arginine- 
dependent mechanism. Incubation of Mcs in the presence 
of t-arginine caused a dose-dependent inhibition  of Me pHi 
recovery from an imposed acid load. The impairment of pHi 
recovery required the presence of t-arginine,  was reversed by 
the addition of t-arginase, and was blocked competitively  by 
N-MMA, a competitive inhibitor of L-arginine metabolism. 
Furthermore, LPS, which is a potent stimulator of Me t-ar- 
ginine metabolism, enhanced the inhibitory effect of t-arginine 
on pHi recovery. Finally, it was the bafilomycin Al-sensitive 
component of the pHi  recovery, which was inhibited by 
t-arginine, implicating an effect on H + pump activity. When 
considered together, these data indicate that a product of t-ar- 
ginine metabolism  by Mcs is able to inhibit the vacuolar- 
type H + ATPases involved in Me pHi regulation. 
The metabolite responsible for this inhibition was inves- 
tigated. Among the stable end products of L-arginine metab- 
olism,  nitrates  are  known  to  inhibit  vacuolar-type  H + 
ATPases. The reported Ki values for this inhibition are in the 
range of 40-100 mM (46-48).  The total amount of nitrate 
released by activated Mcs after 48 h in vitro has been esti- 
mated to reach •400  nmol/106 cells (43). If this amount of 
nitrate remained within the cells, the intracellular concentra- 
tion of nitrate would be predicted to reach well over 100 mM. 
However, since nitrate is a permeant anion, it is unlikely that 
it would remain trapped  in the intracellular compartment, 
and thus the total amount of nitrate generated by L-arginine 
metabolism would likely be distributed throughout the extra- 
and intracellular  compartments. If 10  7 ceils suspended in 
1 ml of medium produced a total of 4 #mol of nitrate,  the 
predicted final concentration of nitrate would reach only 
4 mM, well below the Ki for H + ATPase inhibition.  Thus, 
it  was unlikely that nitrate was the t-arginine metabolite 
responsible for the observed inhibitory effect. Accordingly, 
nitrate in concentrations up to 10 mM failed to inhibit pHi 
recovery. 
Instead, the present studies indicate that the molecular spe- 
cies responsible for L-arginine-dependent inhibition of H + 
pump activity is nitric oxide. Several lines of evidence sup- 
port this concept:  (a) two distinct  nitric oxide scavenging 
systems reversed the effect of t-arginine metabolism on pHi 
recovery; (b) the exogenous nitric oxide-generating agent, 
nitroprusside,  was found to mimic the inhibitory effect of 
L-arginine; (c) nitrite levels were higher in the supernatants 
of cells incubated in t-arginine-containing medium than in 
arginine-free medium; (d) the stable end products of various 
pathways  of t-arginine metabolism  had no effect on pHi 
recovery. Two potential  mechanisms by which nitric oxide 
might impair H § pump activity were investigated. The ATP 
content of Mcs incubated with or without L-arginine was 
equivalent,  making it unlikely that the inhibition resulted 
from a nitric oxide-induced depletion of ATE By contrast, 
the possibility that cGMP mediated the inhibition is sup- 
ported by two findings. First,  nitroprusside  caused a rapid 
inhibition of pHi recovery in association with a marked rise 
in cGMP levels. Second, incubation of Mcs with the mem- 
brane-permeant form of cGMP, 8-bromo cGMP, impaired 
H + ATPase-mediated pHi  regulation.  We were unable  to 
demonstrate elevated cGMP levels in cells incubated in L-ar- 
ginine-containing medium for 4 h, a time point where inhi- 
bition of pHi recovery was clearly evident. This finding sug- 
gests that t-arginine-derived  nitric oxide may exert its effect 
on pHi recovery via a cGMPoindependent mechanism, or al- 
ternatively that the measurement of total intracellular cGMP 
is not sufficiently sensitive to detect small or focal increases 
in cGMP within the cytoplasmic compartment, which might 
be responsible for the inhibition of pHi recovery. 
There are several potential mechanisms through which an 
elevation in intraceUular cGMP might potentially modulate 
H § ATPase activity. One possible mechanism is through ac- 
tivation  of a cGMP-dependent  kinase (49). This appears to 
be the signal transduction pathway through which nitric oxide 
induces relaxation of vascular smooth muscle (43, 50-53), 
inhibits  aggregation of platelets (54), and transmits  signals 
in cerebellar cells (55). In addition,  Semrad et al. (56) have 
recently shown that 8-bromo cGMP inhibits  Na +/H + ex- 
change  in  chicken  enterocytes,  resulting  in  cytoplasmic 
acidification; this effect appeared to be mediated through an 
increase in [Ca 2+ ]i, which was in turn secondary to cGMP- 
dependent phosphorylation. The H § ATPases that regulate 
Me pHi might similarly be modulated by cGMP-dependent 
phosphorylation. 
An additional  possibility  is  that cGMP could indirect- 
ly affect H + ATPases by altering  the intracellular  level of 
cAMP. A family of cAMP phosphodiesterases exists that is 
inhibited by physiological levels of cGMP (49). Increasing 
cGMP could thus potentially lead to decreased cAMP hy- 
drolysis and thereby elevated cAMP levels, which could in 
turn stimulate cAMP-dependent  kinase activity. The effect 
of cAMP on the pHi regulating H + ATPases of Mcs has not 
been examined. Recent studies by Gurich and Dubose (57) 
have demonstrated that 8-bromo cAMP inhibits H § ATPase- 
mediated acidification of endosomal vesicles prepared from 
rabbit renal cortex. Since the H § ATPases that regulate Me 
pHi are of the vacuolar-type, like those located in endosomal 
membranes, one could speculate that they might be similarly 
susceptible to inhibition by cAMP. ATPase-mediated  pumping 
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tion of chloride anions (16), which offsets the electrogenicity 
of H + pumping.  Accordingly,  H + ATPase-mediated pHi 
recovery in Mes is partially dependent on the presence of in- 
tracellular chloride (15). Thus, cAMP could theoretically in- 
hibit H + pumping by decreasing the conductance for the 
counterion, chloride. However, Bae and Verkman (58) have 
recently reported that, in rabbit proximal tubule endosomes, 
counterion conductance is increased  in response to phosphory- 
lation through a cAMP-dependent protein kinase. This sug- 
gests that cAMP would be more likely to inhibit H + pump- 
ing through an effect on H + ATPases themselves, rather 
than through an effect on chloride conductance. 
The present studies have focused on the role of vacuolar- 
type H + ATPases as regulators of Me pHi. However, vacu- 
olar-type H + ATPases are also responsible for acidification 
of a variety of intracellular compartments, including secre- 
tory granules, endosomes and lysosomes, and the Golgi ap- 
paratus (16), as well as phagosomes (59). The ability to acidify 
these organelles is central to many important cellular func- 
tions, including receptor-ligand dissociation, protein sorting 
and degradation,  and microbicidal  activity.  For example, 
phagosomal acidification after microbial ingestion is crucial 
to the maintenance of normal cellular microbicidal function. 
Acidification enhances the activity of acid hydrolases within 
the phagolysosome, promotes the formation of the toxic ox- 
ygen metabolite,  hydrogen peroxide,  and may be directly 
microbicidal. Impairment of vacuolar-type H + ATPases by 
t-arginine metabolism could potentially alter the pH homeo- 
stasis of these organdies and reduce normal microbicidal ac- 
tivity. It is also interesting to note that incubation with con- 
centrations of I:arginine typically present in commercially 
available prepared media (0.4 mM in MEM, 1.14 mM in RPMI 
1640) has been shown to  inhibit  a variety of activation- 
associated functions  in  resident  and  Corynebacterium par- 
vum--elicited  peritoneal Mos, including phagocytosis and pro- 
tein synthesis (32). Inhibition of vacuolar-type H + ATPase 
activity constitutes one mechanism by which t-arginine me- 
tabolism  could interfere with effective Mo function. 
Whether L-arginine metabolism  by Mcs can modulate 
H + ATPase function in vivo is not clear. Estimates  of ex- 
tracellular L-arginine concentrations  range from '~100/xM 
in plasma (32) to <50/~M in healing wounds and inflamma- 
tory sites (60, 61). Incubation of thioglycolate-elicited Mcs 
with t-arginine in this concentration range did not result in 
significant impairment of pHi regulation. However, endo- 
toxin present in the inflammatory milieu could potentially 
enhance metabolism of low concentrations of t-arginine to 
produce significant  amounts of  nitric oxide. Preliminary studies 
indicate that incubation of Mcs with LPS causes inhibition 
of pHi recovery at t-arginine concentrations  as low as 12.5 
/,M. This suggests that the low levels of t-arginine present 
in vivo could modulate pHi regulation of Mcs in which the 
nitric oxide synthase pathway had been activated by stimuli 
present in the septic milieu.  On the other hand, activated 
Mcs release increased amounts of arginase (60-62);  reduc- 
tion of pericellular l:arginine concentrations by this mecha- 
nism may prevent the undesirable sequelae of t-arginine me- 
tabolism  to  nitric oxide.  Enhanced  release of arginase by 
activated Mcs can thus be viewed as a self-protective mecha- 
nism.  This might be of particular  importance to Mcs at- 
tempting to function in the acidic milieu of an abscess, where 
H + ATPase activity is essential to maintenance of pHi (13). 
The present studies investigated proton pump activity in 
moderately activated cells, i.e., those elicited by thioglyco- 
late. Adherence-enriched populations  of resident peritoneal 
macrophages did not demonstrate an t-arginine-dependent 
inhibition of H + ATPase-mediated proton extrusion (pHi 
recovery rate: without l:arginine, 0.11  _+  0.03 pH/min vs. 
with t-arginine, 0.12  _+  0.03 pH/min n  =  5). The finding 
that pHi recovery in adherent thioglycolate-elicited cells in- 
cubated in arginine-free medium was significantly higher than 
in resident cells (0.20 _+ 0.02 pH/min vs. 0.11 _+ 0.03 pH/min; 
p  <  0.05)  suggests  that  the component of H + ATPase- 
mediated phi recovery inhibitable by I:arginine metabolism 
may be induced by Me activation.  Whether this enhanced 
H + ATPase activity occurs via synthesis of new pumps or 
upregulation of existing quiescent pumps after exposure to 
inflammatory stimuli  requires further investigation. 
In summary, metabolism of I.-arginine by Mcs causes in- 
hibition of H § ATPase-mediated pHi  regulation in vitro. 
The evidence that this inhibition may be mediated through 
a nitric oxide-induced elevation of cGMP suggests a novel 
mechanism by  which  the  activity of vacuolar-type  H + 
ATPases may be modulated. Since H + ATPase-mediated pHi 
regulation is critical for effective  Me function within an acidic 
milieu, metabolism of t-arginine to nitric oxide could thus 
lead to impaired Me performance within the inflammatory 
microenvironment. 
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